TRVN: Trevena, Inc. Earnings growth forecast for next year
Strict control of clinic supply chains ensures patient safety during the distribution of Trevena, Inc. (TRVN) analgesics. Assessing future earnings per share growth helps track fluctuations in expert consensus, where 35.80 indicates the level of this metric. Drug production has been fully outsourced to external CMO sites to minimize capital expenditures; however, a critical liquidity shortage and low sales create a risk of a total business shutdown.
Analytical breakdowns for Trevena (TRVN)
- price and consensus price forecast:
- market capitalization information:
- book capitalization indicators:
- debt and liquidity details:
- earnings and market ratios statistics:
TRVN - Final Profit|Future Profit Trevena, Inc.|TRVN - Price to Earnings Ratio|Future Price to Earnings Trevena, Inc|TRVN - Growth-Adjusted P/E Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Trevena Inc|TRVN - Operating profit before amortization|Net earnings per share (EPS TTM) Trevena|TRVN - Net earnings per one share for the last twelve months|Year-over-year net earnings per share growth for the last 12 months trevena.com|TRVN - Earnings growth in current year|Net earnings per share growth forecast for next year Trevena, Inc.
- sales and revenue indicators:
Comprehensive company analysis:trevena.com
A conservative investor is assessing the potential of Trevena, Inc. (TRVN) by analyzing consolidated analyst forecasts for next year's earnings per share. The trend in market expectations for EPS growth reflects the company's ability to monetize hospital analgesics under strict distribution control, where supply chain efficiency directly determines margins and the issuer's ultimate investment profile.
Competitor analysis
Net earnings per share growth forecast for next year Biogen|Expected earnings per share growth for next year neurocrine.com (NBIX)|Net earnings per share growth forecast for next year Regencell Bioscience Holdings Limited (RGC)|AXSM (Axsome Therapeutics Inc) - Expected earnings per share trend next year|Net earnings per share growth forecast for next year ACADIA Pharmaceuticals Inc. ACAD|Expected earnings per share trend next year XENE|Viking Therapeutics - Earnings growth forecast for next year|Expected earnings per share trend next year SUPN (supernus.com)|Catalyst Pharmaceuticals (CPRX) - Net earnings per share growth forecast for next year|Expected net earnings per share growth next year Denali (DNLI)|Net earnings per share growth forecast for next year harmonybiosciences.com|BHVN (Biohaven Pharmaceutical) - Projected earnings per share increase next year|Net earnings per share growth forecast for next year amylyx.com (AMLX)|TRVI: Net earnings per share change forecast for next year|Net earnings per share growth forecast for next year Praxis Precision Medicines Inc PRAX|Consensus forecast of earnings per share growth for next year Anavex Life Sciences Corp. (AVXL)|CeriBell EEG - Earnings growth forecast for next year|Expected net earnings per share growth next year Prothena Corp|ALEC: Earnings growth forecast for next year|Projected earnings per share growth rate for next year ANNX|OMER (Omeros) - Earnings growth forecast for next year|NGNE - Net earnings per one share growth forecast for next year|Net earnings per share growth forecast for next year AC Immune Corp (ACIU)|Projected earnings per share increase next year VYGR|Earnings growth forecast for next year NMRA (neumoratx.com)|SCLX - Expected earnings per share growth for next year|tevogen.com - Earnings growth forecast for next year|Net earnings per one share growth forecast for next year Alpha Cognition Inc. (ACOG)|CGTX: Earnings growth forecast for next year|IKT - Consensus forecast of earnings per share growth for next year|Expected earnings per share growth for next year SAVA|Expected earnings per share growth for next year Assertio (ASRT)|Expected earnings per share growth for next year COYA (Coya)|Net earnings per share growth forecast for next year VTGN (VistaGen Therapeutics Inc)|Net earnings per share growth forecast for next year Ovid Therapeutics OVID|Earnings growth forecast for next year Acumen Pharma ABOS|CervoMed, Inc. - Earnings growth forecast for next year|Expected earnings per share trend next year ATHE (alteritytherapeutics.com)|CLNN (Clene Nanomedicine) - Expected earnings per share growth for next year|Expected net earnings per share growth next year PepGen Corp (PEPG)|Net earnings per share growth forecast for next year Jupiter Neurosciences Inc|Expected net earnings per share growth next year Relmada Therapeutics RLMD|Net earnings per share growth forecast for next year Annovis Bio (ANVS)|GRCE - Expected net earnings per share growth next year|Earnings growth forecast for next year AIFF (Firefly Neuroscience, Inc)|Klotho Neurosciences Inc (KLTO) - Expected net earnings per share growth next year|NeuroSense Therapeutics, Ltd. - Earnings growth forecast for next year|RVPH - Earnings growth forecast for next year|MetaVia Inc (MTVA) - Net earnings per share growth forecast for next year|NRXS - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year heliusmedical.com|PASG - Net earnings per one share growth forecast for next year|Net earnings per share growth forecast for next year Neuphoria (NEUP)|Consensus forecast of earnings per share growth for next year Minerva|Earnings growth forecast for next year ATHA (Athira Pharma Corp)|Expected earnings per share trend next year ADXN|Alzamend - Earnings growth forecast for next year|Cyclerion Therapeutics, Inc. (CYCN) - Expected earnings per share growth for next year|protagenic.com (PTIX) - Net earnings per share growth forecast for next year|KTTA: Projected earnings per share increase next year|CRGT (cortigent.com) - Earnings growth forecast for next year|ATXI (Avenue Therapeutics) - Projected earnings per share increase next year|Earnings growth forecast for next year BCLI|Projected earnings per share increase next year CARA|Net earnings per share growth forecast for next year chromocell.com CHRO|Earnings growth forecast for next year Eliem Therapeutics ELYM|ITCI: Expected earnings per share growth for next year|LBPH: Net earnings per share growth forecast for next year|MRNS (Marinus Pharmaceuticals, Inc.) - Expected earnings per share growth for next year|NKGen - Expected earnings per share trend next year|Net earnings per share growth forecast for next year NeuroBo Pharmaceuticals, Inc.|Earnings growth forecast for next year Sage Therapeutics Inc|Earnings growth forecast for next year SNPX|VIGL - Expected net earnings per share growth next year|Anew Medical Inc. - Expected earnings per share growth for next year|CERE (Cerevel Therapeutics, Inc.) - Net earnings per share change forecast for next year
